Analysts/Mike DiFiore

Mike DiFiore

Healthcare

Limited coverage. Only 1 question of coverage. Treat these numbers as directional — sample too small for reliable averages.

1

Companies

1

Questions

Focus Areas1 topics

Innovation & R&D1

Question History1 questions

AMGNAmgen Inc.1 quarter

2025 Q3

There is some confusion on whether we'll get two-year weight loss data in the upcoming Part 2 readout of the MariTide obesity Phase II trial.